PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
CD4 112,219 Target Disease Inflammatory Bowel Disease 24,375 709 0.01 -0.98 0.03 0.62
CD4 112,219 Target Disease Pneumonia 81,521 1,696 0.02 -0.98 0.02 0.63
CD4 112,219 Target Disease Rheumatoid Arthritis 78,952 1,711 0.02 -0.98 0.02 0.63
CD4 112,219 Target Disease Inflammatory Bowel Diseases 4,684 165 0.01 -0.98 0.04 0.60
CD4 112,219 Target Drug Antabuse (Disulfiram)- FDA 27 1 0.00 -0.98 0.04 0.57
CD4 112,219 Target Target Apo-SAA 27 1 0.00 -0.98 0.04 0.57
CD4 112,219 Target Target Eotaxin-3/CCL26 26 1 0.00 -0.98 0.04 0.57
CD4 112,219 Target Disease Arthritis 128,324 2,405 0.02 -0.98 0.02 0.63
CD4 112,219 Target Disease Leukemia 162,805 2,675 0.02 -0.98 0.02 0.62
CD4 112,219 Target Target Hiv-1 Integrase 1,199 48 0.00 -0.98 0.04 0.59
CD4 112,219 Target Disease Leishmaniasis 15,049 556 0.01 -0.98 0.04 0.62
CD4 112,219 Target Disease Drug Hypersensitivity 902 38 0.00 -0.98 0.04 0.59
CD4 112,219 Target Target Ns3 3,189 139 0.01 -0.98 0.04 0.61
CD4 112,219 Target Target DC-CK1 22 1 0.00 -0.98 0.05 0.57
CD4 112,219 Target Target BAFFR 44 2 0.00 -0.98 0.05 0.57
CD4 112,219 Target Target CXCL2 750 34 0.00 -0.98 0.05 0.59
CD4 112,219 Target Target CAMK1D 21 1 0.00 -0.98 0.05 0.57
CD4 112,219 Target Target Toll-Like Receptor 2 2,174 103 0.01 -0.98 0.05 0.61
CD4 112,219 Target Target CD34 24,598 988 0.02 -0.98 0.04 0.64
CD4 112,219 Target Target Galectin-1 1,131 55 0.00 -0.98 0.05 0.60
CD4 112,219 Target Target CCL2 3,560 172 0.01 -0.97 0.05 0.61
CD4 112,219 Target Target COP-1 118 6 0.00 -0.97 0.05 0.58
CD4 112,219 Target Disease Tuberculosis 146,217 3,295 0.03 -0.97 0.03 0.64
CD4 112,219 Target Disease Hepatitis 163,842 3,522 0.03 -0.97 0.03 0.64
CD4 112,219 Target Target Complement Decay-Accelerating Factor 19 1 0.00 -0.97 0.05 0.57
CD4 112,219 Target Target AMAC-1 19 1 0.00 -0.97 0.05 0.57
CD4 112,219 Target Target CXCL7 76 4 0.00 -0.97 0.05 0.58
CD4 112,219 Target Disease Retinitis 9,116 450 0.01 -0.97 0.05 0.63
CD4 112,219 Target Target Apo I 55 3 0.00 -0.97 0.05 0.58
CD4 112,219 Target Target CCL7 274 15 0.00 -0.97 0.05 0.59
CD4 112,219 Target Disease Relapsing Remitting Multiple Sclerosis 2,115 115 0.01 -0.97 0.05 0.61
CD4 112,219 Target Target BAFF 1,240 68 0.01 -0.97 0.05 0.60
CD4 112,219 Target Drug Abatacept (Orencia)- FDA 18 1 0.00 -0.97 0.06 0.57
CD4 112,219 Target Drug Aldara (Imiquimod)- FDA 36 2 0.00 -0.97 0.06 0.58
CD4 112,219 Target Disease Cancer 1,053,491 5,766 0.02 -0.97 0.05 0.57
CD4 112,219 Target Target ELC 355 21 0.00 -0.97 0.06 0.59
CD4 112,219 Target Disease Cryptococcosis 3,853 244 0.01 -0.97 0.06 0.62
CD4 112,219 Target Target CCL18 256 17 0.00 -0.97 0.07 0.59
CD4 112,219 Target Target CXCL10/IP-10 114 8 0.00 -0.96 0.07 0.59
CD4 112,219 Target Target Eotaxin 2,457 171 0.01 -0.96 0.07 0.62
CD4 112,219 Target Drug Abacavir Sulfate 41 3 0.00 -0.96 0.07 0.58
CD4 112,219 Target Disease Arthritis Juvenile 27 2 0.00 -0.96 0.07 0.58
CD4 112,219 Target Target CD148 74 6 0.00 -0.96 0.08 0.59
CD4 112,219 Target Disease Leprosy Lepromatous 12 1 0.00 -0.96 0.08 0.58
CD4 112,219 Target Drug Arranon (Nelarabine)- FDA 12 1 0.00 -0.96 0.08 0.58
CD4 112,219 Target Disease HIV/AIDS 20,397 1,477 0.03 -0.96 0.07 0.66
CD4 112,219 Target Target CCL8 197 17 0.00 -0.96 0.09 0.60
CD4 112,219 Target Drug Aptivus (Tipranavir)- FDA 23 2 0.00 -0.96 0.09 0.58
CD4 112,219 Target Target CCL3 1,427 127 0.01 -0.95 0.09 0.62
CD4 112,219 Target Drug Atovaquone (Mepron)- FDA 11 1 0.00 -0.95 0.09 0.58